Chestoflo-F 250

Breathe in Resilience, Breathe out Asthma


Composition: Fluticasone Propionate IP 250 mcg + Formoterol Fumarate Dihydrate IP 6 mcg Inhaler

  • Combination of Fluticasone and Formoterol acts synergistically to enhance therapeutic effect & patient adherence.
  • Provides rapid and dose dependent bronchodilatory action within 1-3 minutes.
  • Exerts potent & sustained anti-inflammatory action than salbutamol.


  • Mild, Moderate or Moderate-Severe Asthma
  • Nasopharyngitis
  • Allergic Rhinitis
  • Emphysema

Fluticasone Propionate

  • An effective, well-established inhaled corticosteroid, that provides sustained anti-inflammatory effects.

Formoterol fumarate

  • Long-acting β2-antagonist with a fast onset of action


  • Fluticasone/formoterol provides clinically significant improvements in lung function and asthma control measures, with a lower incidence of exacerbations.
  • It is superior to fluticasone alone and non-inferior to fluticasone/salmeterol in terms of effects on lung function.
Scroll to Top